Key facts
- This page summarizes Josep Llorens's Form 4 filing for HAEMONETICS CORP (HAE).
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 20 Jul 2023, 16:17.
Josep Llorens - 18 Jul 2023 Form 4 Insider Report for HAEMONETICS CORP (HAE)
- Reporting relationship
- EVP, Global Manufacturing
- Issuer ticker
- HAE
- Reported as of
- 18 Jul 2023
- Net transaction value
- -$162,130
- SEC form
- 4
- Accepted by SEC
- 20 Jul 2023, 16:17:43 UTC
- Prior SEC filing
- 19 May 2023
- Next SEC filing
- 17 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas V. Powers, attorney-in-fact for Mr. Llorens
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Josep Llorens filed Form 4 for HAEMONETICS CORP (HAE) on 20 Jul 2023.
Change
- Previous filing in this sequence was filed on 19 May 2023.
- Current net transaction value: -$162,130.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HAE
transaction
Common Stock
Options Exercise
- Transaction value
- $135,259
- Shares
- +2,391
- Change %
- +13%
- Price
- $56.57
- Shares after
- 20,854
- Date
- 18 Jul 2023
- Ownership
- Direct
- Footnotes
- F1, F2
HAE
transaction
Common Stock
Options Exercise
- Transaction value
- $146,131
- Shares
- +2,537
- Change %
- +12%
- Price
- $57.60
- Shares after
- 23,391
- Date
- 18 Jul 2023
- Ownership
- Direct
- Footnotes
- F1, F2
HAE
transaction
Common Stock
Sale
- Transaction value
- $443,520
- Shares
- -4,928
- Change %
- -21%
- Price
- $90.00
- Shares after
- 18,463
- Date
- 18 Jul 2023
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HAE
transaction
Derivative
Non-qualified Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,391
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 4,782
- Date
- 18 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,391
- Exercise price
- $56.57
- Footnotes
- F1, F3
HAE
transaction
Derivative
Non-qualified Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,537
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 7,611
- Date
- 18 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,537
- Exercise price
- $57.60
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
Transaction pursuant to an existing 10b5-1 trading plan dated August 22, 2022.
Footnote F2
This number includes unvested restricted stock units previously reported.
Footnote F3
Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.